期刊文献+

纳米刀治疗晚期胰腺癌病例1例 预览

One case of advanced pancreatic cancer treated with nanoknife
在线阅读 下载PDF
收藏 分享 导出
摘要 胰腺癌是一种恶性程度较高,诊断和治疗都很困难的消化道恶性肿瘤;近年来,其发病率和死亡率均明显升高。胰腺癌早期确诊率不高,手术治愈率较低,化疗、放疗等辅助治疗效果亦不佳。相关文献报道,纳米刀作为一项新兴的肿瘤消融治疗技术,在晚期癌症的局部治疗中具有一定的效果。对我院收治的1例晚期胰腺癌患者实施纳米刀胰腺肿瘤消融+胃肠吻合+肠肠吻合+腹腔低渗温热灌注治疗,术后22d患者病情好转后出院,现对其具体情况进行分析。 Pancreatic cancer is a malignant gastrointestinal malignancy with high degree of malignancy and difficult diagnosis and treatment.In recent years,its morbidity and mortality have increased significantly.The early diagnosis rate of pancreatic cancer is not high;the cure rate of operation is low,and the adjuvant therapeutic effects of chemotherapy and radiotherapy are also poor.Relevant literatures reported that nanoknife has a certain effect in the local treatment of advanced cancer as a new technology of tumor ablation.A patient with advanced pancreatic cancer in our hospital was treated with nanoknife pancreatic cancer ablation+gastrointestinal anastomosis+intestinal anastomosis+intraperitoneal hypotonic hyperthermia perfusion.The patient was discharged at 22 days after surgery,and the specific situation was analyzed.
作者 张喆 任冯刚 李青山 吕毅 ZHANG Zhe;REN Feng-gang;LI Qing-shan;LV Yi(Hepatobiliary Surgery Department,the First Affiliated Hospital of Xi'an Jiaotong University/National Local Joint Engineering Research Center for Precision Surgery and Regenerative Medicine,Xi'an 710061,China)
出处 《临床医学研究与实践》 2019年第9期140-142,共3页 CLINCAL RESEARCH AND PRACTICE
基金 国家自然科学基金(No.81727802)。
关键词 晚期 胰腺癌 纳米刀 肿瘤消融 advanced pancreatic cancer nanoknife tumor ablation
作者简介 张喆(1993-),男,汉族,江苏苏州人,住院医师,硕士在读。研究方向:肝胆胰脾疾病外科治疗;通讯作者:吕毅,E-mail:luyi169@126.com.
  • 相关文献

参考文献12

二级参考文献107

  • 1陈雪松(综述),隋广杰(审校).胰腺癌治疗的研究进展[J].实用肿瘤学杂志,2005,19(4):316-319. 被引量:8
  • 2赵玉沛.中国胰腺癌治疗20年的成绩和需研究的问题[J].外科理论与实践,2007,12(3):193-195. 被引量:34
  • 3高顺良,陈健,王涌,吴育连.Whipple术后胰肠吻合口大出血的急诊手术治疗[J].中华急诊医学杂志,2007,16(8):870-871. 被引量:5
  • 4胰腺癌诊治指南[J].中华外科杂志,2007,45(19):1297-1299. 被引量:12
  • 5Siegel R,Ma J,Zou Z,et al.Cancer statistics,2014[J].CA Cancer J Clin,2014,64(1):9-29. 被引量:1
  • 6National Comprehensive Cancer Network.Clinical Practice Guidelines in Oncology.Pancreatic Adenocarcinoma[S].Version 2.2014.http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. 被引量:1
  • 7Tol JA,Gouma DJ,Bassi C,et al.Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma:a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS)[J].Surgery,2014,156 (3):591-600. 被引量:1
  • 8Bockhorn M,Uzunoglu FG,Adham M,et al.Borderline resectable pancreatic cancer:a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS)[J].Surgery,2014,155 (6):977-988. 被引量:1
  • 9Hartwig W,Vollmer CM,Fingerhut A,et al.Extended pancreatectomy in pancreatic ductal adenocarcinoma:definition and consensus of the International Study Group for Pancreatic Surgery (ISGPS).Surgery,2014,156(1):1-14. 被引量:1
  • 10Asbun HJ,Conlon K,Fernandez-Cruz L,et al.When to perform a pancreatoduodenectomy in the absence of positive histology? A consensus statement by the International Study Group of Pancreatic Surgery[J].Surgery,2014,155 (5):887-892. 被引量:1

共引文献122

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈
新型冠状病毒肺炎防控与诊疗专栏